arginine has been researched along with cyclosporine in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.97) | 18.7374 |
1990's | 50 (48.54) | 18.2507 |
2000's | 35 (33.98) | 29.6817 |
2010's | 17 (16.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Farrand, SK; Hamada, SE | 1 |
Hoffman, RA; Langrehr, JM; Lee, TK; Müller, AR; Schraut, WH; Simmons, RL | 1 |
Boyle, JG; Fenn, JB; Whitehouse, CM | 1 |
Badger, AM; Bugelski, PJ; Kaplan, JM; Newman-Tarr, T; Olivera, DL; Ruggieri, EV | 1 |
Bartlett, ST; Curry, DL; Gillison, SL | 1 |
Berkenboom, G; Fang, ZY; Fontaine, J; Goldman, M; Unger, P | 1 |
Alexander, JW; Levy, AE | 1 |
Bonfoco, E; Ceccatelli, S; Manzo, L; Nicotera, P | 1 |
Amore, A; Bussolino, F; Cacace, G; Costamagna, C; Ghigo, D; Gianoglio, B; Mazzucco, G; Peruzzi, L; Picciotto, G; Porcellini, MG | 1 |
Barker, CV; Curtis, JJ; Gaston, RS; Sanders, PW; Schlessinger, SD; Warnock, DG | 1 |
Badalamenti, S; Como, G; Finazzi, S; Galmarini, D; Paone, G; Ponticelli, C; Tarantino, A; Viganò, E | 1 |
Pittelkow, MR; Robertson, RP; Seaquist, ER; Teuscher, AU | 1 |
Chatterjee, K; Chou, TM; De Groot, CJ; DeMarco, T; MacGregor, JS; Sudhir, K; Taylor, RN; Yock, PG | 1 |
Alvarado, JA; Bobadilla, NA; Franco, M; García-Torres, R; Herrera-Acosta, J; López, P; Mendoza, S; Tapia, E | 1 |
Conger, JD; Kim, GE; Robinette, JB | 1 |
Caramelo, CA; Casado, S; Gallego, MJ; García Villalón, AL; García, JL; Garrón, MP; Hernando, L; López Farre, AJ | 1 |
Robertson, RP; Seaquist, ER; Teuscher, AU | 1 |
Barat, A; Caramelo, CA; Casado, S; Gallego, MJ; Grandes, SM; Hernando, L; Lopez Farre, A; Monton, M; Riesco, A | 1 |
Brown, MR; De Nicola, L; Gabbai, FB; Thomson, SC; Wead, LM | 1 |
Barthelmebs, M; Billing, A; Fabre, M; Grima, M; Hofner, M; Imbs, JL; Krieger, JP; Stephan, D | 1 |
Andoh, TF; Bennett, WM; Gardner, MP; Houghton, DC; Lindsley, J | 1 |
Choi, KH; Han, DS; Kang, BS; Kang, SW; Kim, DH; Kim, HS; Lee, HY; Lee, YH | 1 |
Akiyama, K; Bing, RJ; Cannavino, C; Grant, P; Horstman, D; Suzuki, H; Wolf, WP | 1 |
Assan, R; Boitard, C; Deschamps, I; Jos, J; Laborde, K; Rakotoambinina, B; Robert, JJ; Timsit, J | 1 |
Carrier, M; Khalil, A; Latour, JG; Pelletier, LC | 1 |
Foegh, ML; Katz, N; Kodama, T; Lou, H; Ramwell, P; Wang, YN | 1 |
Assis, SM; Monteiro, JL; Seguro, AC | 1 |
Benet, LZ; Berg-Candolfi, M; Candolfi, E | 1 |
Bernardi, P; Eriksson, O; Fontaine, E; Petronilli, V | 1 |
Andrés, A; Campo, C; García-Robles, R; Lahera, V; Morales, JM; Praga, M; Rodicio, JL; Ruilope, LM | 1 |
Carrier, M; Dupuis, J; Mathieu, P; Pelletier, LC; Ryan, J | 1 |
Andoh, TF; Bennett, WM; Gardner, MP | 1 |
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE | 1 |
Keiser, HR; Oriji, GK | 2 |
Bartholomeusz, B; Hardy, KJ; Nelson, AS; Phillips, PA | 1 |
Dolinski, K; Heitman, J; Maier, P; Schmid, FX; Scholz, C | 1 |
Eichler, HG; Fuchs, C; Koller-Strametz, J; Laufer, G; Mensik, C; Putz, D; Schmetterer, L; Wisser, W; Wolzt, M | 1 |
Alexander, JW; Babcock, GF; Custer, DA; Gibson, SW; Ogle, CK; Valente, JF | 1 |
Akiguchi, I; Tomimoto, H | 1 |
Ardissino, G; Claris-Appiani, A; Daccò, V; Ghio, L; Testa, S; Tirelli, AS; Zhang, XZ | 1 |
Oriji, GK | 1 |
Choi, KC; Kang, DG; Kim, NH; Kim, SW; Kook, H; Lee, J | 1 |
Andreucci, VE; De Nicola, L; Nappi, F; Sabbatini, M; Sansone, G; Uccello, F | 1 |
Alexander, JW; Babcock, GF; Custer, DA; Frede, S; Gibson, SW; Li, BG; Ogle, CK; Valente, JF | 1 |
Andoh, TF; Bennett, WM; Shihab, FS; Yi, H | 1 |
Garlington, S; Khavari, PA; Kirschberg, T; Kreider, E; Lin, Q; McGrane, PL; Rothbard, JB; Wender, PA | 1 |
Clementi, G; Cutuli, VM; Fiore, CE; Messina, R; Pennisi, P; Prato, A | 1 |
Chiu, SC; Fu, E; Liu, D; Tz-Chong, C | 1 |
Amico-Roxas, M; Caruso, A; Clementi, G; Cutuli, VM; Fiore, CE; Mangano, NG; Matera, M; Pennisi, P; Prato, A | 1 |
Charpie, JR; Crowley, DC; D'Alecy, L; Goldberg, CS; Gomez, CA | 1 |
Finckenberg, P; Lassila, M; Moilanen, E; Nurminen, ML; Riutta, A; Salmenperä, P; Santisteban, J; Vapaatalo, H; Virtanen, I | 1 |
Azevedo, I; Keating, E; Martel, F | 1 |
Ardissino, G; Claris-Appiani, A; Colombo, D; Daccò, V; Ghio, L; Pace, E; Testa, S; Tirelli, AS; Zhang, XZ | 1 |
Dyer, PA; Haworth, SE; Hull, PS; Irwin, CR; James, JA; Linden, GJ; Marley, JJ; Maxwell, AP; McNamee, P; Middleton, D; Poulton, KV; Short, CD | 1 |
Bohdanecká, M; Bubenícek, P; Kazdová, L; Matl, I; Skibová, J; Táborský, P; Teplan, V; Veselá, J | 1 |
Levi, M; Moons, AH; Peters, RJ | 1 |
Ishii, M; Kiuchi, Y; Shimizu, S; Shiota, K; Yamamoto, S; Yamamoto, T | 1 |
Dehpour, AR; Homayoun, H; Khavandgar, S | 1 |
Al-Majed, A; Al-Rikabi, A; Daba, MH; Gado, A; Mansour, M | 1 |
Dehpour, AR; Homayoun, H; Khavandgar, S; Namiranian, K | 1 |
Dean, SK; Keogh, GW; Roberts, S; Scott, H; Tuch, BE | 1 |
Fujimura, A; Nishiki, K; Purkerson, JM; Schwartz, GJ; Tsuruoka, S; Wakaumi, M; Yamamoto, H | 1 |
Endoh, M; Ikegaya, N; Kumagai, H; Odamaki, M | 1 |
Berne, C; Felldin, M; Foss, A; Källen, R; Korsgren, O; Moberg, L; Nilsson, B; Olsson, A; Salmela, K; Tibell, A; Tufveson, G | 1 |
El-Gowilly, SM; El-Mas, MM; Mohy El-Din, MM; Sharabi, FM | 1 |
Davis, NA; Inman, SR; Lukaszek, VA; Mazzone, ME; Olson, KM; Yoder, KN | 1 |
Chander, V; Chopra, K | 1 |
Bernardi, P; Costantini, P; Eriksson, O; Franck, M; Greci, L; Johans, C; Johans, M; Kinnunen, PK; Liobikas, J; Milanesi, E; Panagiotaki, M; Principato, G | 1 |
Bay, A; Eşrefoğlu, M; Kuruş, M; Oztürk, F | 1 |
Acikel, C; Aslan, I; Bozlar, U; Caglar, K; Cakir, E; Erbil, K; Eyileten, T; Oguz, Y; Ozcan, O; Ozgurtas, T; Saglam, M; Sonmez, A; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
Alexander, JW; Alloway, R; Austin, J; Buell, JF; Cardi, M; Fidler, JP; Goel, S; Goodman, HR; Hanaway, M; Huang, S; Munda, R; Roy-Chaudhury, P; Safdar, S; Susskind, B; Trofe, J; Woodle, ES | 1 |
Blanton, A; Hercule, H; Nsaif, R; Oyekan, A | 1 |
Esrefoglu, M; Karabulut, AB; Kaya, M; Kurus, M; Otlu, A; Sogutlu, G | 1 |
Carlsson, U; Hammarström, P; Moparthi, SB | 1 |
Kumar, A; Kumar, P | 1 |
Di Marco, P; Doutreleau, S; Geny, B; Lonsdorfer, E; Piquard, F; Richard, R; Rouyer, O | 1 |
Abd-Elrahman, KS; Abdel-Galil, AG; El-Gowelli, HM; El-Mas, MM; Saad, EI | 1 |
El-Dayem, WA; Eladl, M; Elgalaly, H; Kamel, M; Maarouf, AM; Radwan, M; Salem, EA; Salem, NA | 1 |
Fletcher, JS; Kordys, J; Lockyer, NP; Piwowar, AM; Vickerman, JC; Winograd, N | 1 |
Drozdzik, M; Dziewanowski, K; Kozak, M; Kurzawski, M; Lapczuk, J; Lipski, M; Wajda, A | 1 |
Akay, OM; Bal, C; Gulbas, Z; Sahin, G; Yalcin, AU | 1 |
Akyuz, F; Birdane, A; Degirmenci, NA; Musmul, A; Ozkurt, S; Sahin, G; Tek, M; Tekin, N; Temiz, G; Yalcin, AU | 1 |
Bahry, D; Ben Tur, O; Chernichovski, T; Chernin, G; Grupper, A; Levi, S; Pri-Paz, Y; Schwartz, IF; Shashar, M | 1 |
Chalvignac, V; Lacarelle, B; Mouly-Bandini, A; Picard, N; Sampol-Manos, E; Sanchez, R | 1 |
Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P | 1 |
Akay, OM; Bal, C; Gulbas, Z; Sahin, G; Uslu, S; Yalcin, AU | 1 |
Deng, J; Liu, C; Lv, H; Yin, L; Zhang, Z; Zhou, J | 1 |
Hewedy, WA; Mostafa, DK | 1 |
Boiocchi, M; Colussi, AM; De Appollonia, L; Freschi, A; Galligioni, E; Gigante, M; Sandrin, A; Sorio, R; Talamini, R; Toffoli, G | 1 |
Bertrand, R; Jenkins, J; Pommier, Y; Solary, E | 1 |
Gonzalez, FJ; Korzekwa, KR; Nemec, J; Relling, MV; Schuetz, EG; Schuetz, JD | 1 |
Hill, BT; Hosking, LK | 1 |
Budning, A; Chan, HS; DeBoer, G; Gallie, BL; Koren, G; Ling, V; Thiessen, JJ; Verjee, Z | 1 |
Boiocchi, M; Corona, G; Galligioni, E; Gigante, M; Sorio, R; Toffoli, G | 1 |
Budning, A; Chan, HS; DeBoer, G; Gallie, BL; Giesbrecht, E; Haddad, G; Hungerford, JL; Kingston, JE; Koren, G; Ling, V; O'Brien, JM; Thiessen, JJ; Verjee, Z | 1 |
Aita, P; Bertola, A; Boiocchi, M; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G | 1 |
Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF | 1 |
3 review(s) available for arginine and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The role of immunologic reactions in the pathogenesis in Binswanger's disease; a clue to therapeutic approach].
Topics: Animals; Antithrombins; Arginine; Blood Coagulation Factors; Brain; Brain Ischemia; Cyclosporine; Dementia, Vascular; Humans; Immunosuppressive Agents; Neuroglia; Pipecolic Acids; Sulfonamides; Thrombin | 1999 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
9 trial(s) available for arginine and cyclosporine
Article | Year |
---|---|
Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients.
Topics: Arginine; Azathioprine; Cyclosporine; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Kidney Transplantation; Reference Values; Renal Circulation | 1994 |
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Reference Values | 1995 |
Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
Topics: Aged; Arginine; Blood Pressure; Chronic Disease; Cohort Studies; Cyclosporine; Glomerular Filtration Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Kidney Diseases; Male; Middle Aged; Nitric Oxide; Nitroprusside; Renal Circulation; Vasodilator Agents | 1999 |
Renal and metabolic effects of L-arginine infusion in kidney transplant recipients.
Topics: Adolescent; Adult; Arginine; Child; Cyclic GMP; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Transplantation; Male; p-Aminohippuric Acid; Reference Values; Sodium; Vascular Resistance | 1999 |
L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction.
Topics: Adolescent; Arginine; Child; Cyclosporine; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Time Factors | 2001 |
Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancer.
Topics: Aged; Bilirubin; Carcinoma, Renal Cell; Cell Count; Cyclosporine; Female; Granulocytes; Humans; Kidney Neoplasms; Male; Middle Aged; Pilot Projects; Teniposide | 1995 |
Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Teniposide | 1997 |
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation.
Topics: Antineoplastic Agents; Area Under Curve; Carboplatin; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypophosphatemia; Infant; Infant, Newborn; Retinal Neoplasms; Retinoblastoma; Teniposide; Treatment Outcome; Vincristine; Weight Loss | 1996 |
Effect of cyclosporin A on protein binding of teniposide in cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Bilirubin; Blood Proteins; Carcinoma, Renal Cell; Cyclosporine; Drug Interactions; Female; Half-Life; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Protein Binding; Teniposide | 1999 |
91 other study(ies) available for arginine and cyclosporine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Diversity among B6 strains of Agrobacterium tumefaciens.
Topics: Arginine; Bacteriophages; Ketoses; Lactose; Lysogeny; Plant Tumors; Plasmids; Rhizobium; Species Specificity | 1980 |
Serum NO2-/NO3- from oxidative L-arginine metabolism: a possible marker for small bowel allograft rejection.
Topics: Animals; Arginine; Biomarkers; Cyclosporine; Graft Rejection; Intestine, Small; Nitrates; Nitrites; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1992 |
An ion-storage time-of-flight mass spectrometer for analysis of electrospray ions.
Topics: Arginine; Cyclosporine; Cytochrome c Group; Mass Spectrometry; Molecular Weight | 1991 |
Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Topics: Animals; Arginine; Arthritis; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indomethacin; Interleukin-2; Lymphocyte Activation; Male; omega-N-Methylarginine; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Spiro Compounds; Spleen; Time Factors; Tumor Cells, Cultured | 1991 |
Inhibition by cyclosporine of insulin secretion--a beta cell-specific alteration of islet tissue function.
Topics: Analysis of Variance; Animals; Arginine; Calcium; Cyclosporine; Glucagon; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Male; Organ Size; Radioimmunoassay; Rats; Rats, Inbred Strains; Somatostatin; Time Factors | 1991 |
Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline.
Topics: Acetylcholine; Animals; Arginine; Colforsin; Cyclosporine; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Depolarizing Agents; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Phenylephrine; Rats; Rats, Inbred Strains; Vascular Diseases | 1991 |
Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
Topics: Adjuvants, Immunologic; Animals; Arginine; Blood Transfusion; Cyclosporine; Diet; Drug Synergism; Fish Oils; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Rats; Rats, Inbred ACI; Rats, Inbred Lew; RNA | 1995 |
Colchicine induces apoptosis in cerebellar granule cells.
Topics: Amino Acid Oxidoreductases; Animals; Apoptosis; Arginine; Calcium; Cell Survival; Cells, Cultured; Cerebellum; Colchicine; Cyclosporine; Dizocilpine Maleate; DNA; Kinetics; Neurons; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Paclitaxel; Rats; Rats, Sprague-Dawley; tau Proteins; Time Factors; Tubulin | 1995 |
A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Creatinine; Cyclic GMP; Cyclosporine; Hemodynamics; Isoenzymes; Kidney; Male; Nitric Oxide; Nitric Oxide Synthase; Proteinuria; Rats; Rats, Inbred Lew; Renal Circulation; RNA, Messenger | 1995 |
Cyclosporine inhibits the renal response to L-arginine in human kidney transplant recipients.
Topics: Adult; Amino Acids, Branched-Chain; Arginine; Cyclosporine; Female; Hemodynamics; Humans; Kidney; Kidney Transplantation; Male; Renal Circulation | 1995 |
[The effect of long-term cyclosporin and prednisone therapy on insulin secretory reserve].
Topics: Adult; Analysis of Variance; Arginine; Blood Glucose; Cyclosporine; Female; Humans; Insulin; Insulin Secretion; Male; Prednisone; Time Factors | 1994 |
Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.
Topics: Acetylcholine; Animals; Arginine; Arteries; Coronary Circulation; Coronary Vessels; Cyclosporine; Dogs; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Pericardium; Vascular Resistance; Vasodilation | 1994 |
Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Hemodynamics; Kidney Diseases; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction | 1994 |
Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction.
Topics: Angiotensin Receptor Antagonists; Animals; Arginine; Cyclosporine; Endothelins; Glomerular Filtration Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Renal Circulation; Vasoconstriction | 1994 |
Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+.
Topics: Animals; Aorta; Arginine; Calcium; Cyclic GMP; Cyclosporine; Endothelium, Vascular; Femoral Artery; In Vitro Techniques; Male; Nitric Oxide; Rats; Rats, Wistar; Vasodilation | 1994 |
Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.
Topics: Adult; Arginine; Arthritis; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Psoriasis; Transplantation, Homologous | 1994 |
Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine.
Topics: Acetylcholine; Animals; Arginine; Atrial Natriuretic Factor; Cyclosporine; Diuresis; Endothelium, Vascular; Guanosine Monophosphate; Male; Natriuresis; Nitroprusside; Rats; Rats, Wistar; Vasodilation | 1993 |
Arginine feeding modifies cyclosporine nephrotoxicity in rats.
Topics: Administration, Oral; Angiotensin II; Animals; Arginine; Capillaries; Cyclosporine; Glomerular Filtration Rate; Hydrostatic Pressure; Kidney; Kidney Glomerulus; Male; Nephrons; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance | 1993 |
Endothelium-dependent relaxation in the isolated rat kidney: impairment by cyclosporine A.
Topics: Animals; Arginine; Body Weight; Cholic Acids; Cyclosporine; Endothelium, Vascular; Immunosuppressive Agents; Indomethacin; Kidney; Male; NG-Nitroarginine Methyl Ester; Perfusion; Rats; Rats, Wistar; Vasodilation | 1995 |
Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.
Topics: Animals; Arginine; Body Weight; Cyclosporine; Diet, Sodium-Restricted; Enzyme Inhibitors; Hemodynamics; Kidney Cortex; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
L-arginine restores suppressed acetylcholine-induced endothelium-dependent vascular relaxation in cyclosporine A-treated rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Cyclosporine; Endothelium, Vascular; Immunosuppressive Agents; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 1996 |
Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle.
Topics: Animals; Arginine; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Heart; Isothiuronium; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rabbits | 1996 |
Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Animals; Arginine; Coronary Circulation; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Female; Hemodynamics; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Nitroglycerin; Vasoconstriction | 1996 |
L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
Topics: Animals; Antineoplastic Agents; Aorta; Arginine; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Hyperplasia; Immunosuppressive Agents; Insulin-Like Growth Factor I; Interleukin-6; Macrophages; Male; Nitric Oxide; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous | 1996 |
L-Arginine and allopurinol protect against cyclosporine nephrotoxicity.
Topics: Allopurinol; Animals; Arginine; Cyclosporine; Enzyme Inhibitors; Glomerular Filtration Rate; Inulin; Kidney Diseases; Male; Nitrates; Nitric Oxide; Nitrites; Potassium; Rats; Xanthine Oxidase | 1997 |
Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Arginine; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Interferon-gamma; Intestinal Mucosa; Jejunum; Macrophages, Peritoneal; Male; Mice; Mice, Inbred CBA; Microsomes; Microsomes, Liver; Nitrites; Oxidoreductases, N-Demethylating; Toxoplasmosis, Animal | 1996 |
Inhibition of the mitochondrial cyclosporin A-sensitive permeability transition pore by the arginine reagent phenylglyoxal.
Topics: Animals; Arginine; Calcium; Cyclosporine; Indicators and Reagents; Intracellular Membranes; Male; Mitochondria, Liver; Oxygen Consumption; Permeability; Phenylglyoxal; Rats; Rats, Wistar | 1997 |
L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients.
Topics: Adult; Arginine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Natriuresis | 1997 |
L-arginine prevents cyclosporin A-induced pulmonary vascular dysfunction.
Topics: Acetylcholine; Animals; Arginine; Atrial Function, Left; Blood Pressure; Bradykinin; Cyclooxygenase Inhibitors; Cyclosporine; Dogs; Endothelium, Vascular; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Peptidyl-Dipeptidase A; Pulmonary Artery; Pulmonary Circulation; Substance P; Vasodilation; Vasodilator Agents | 1997 |
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1997 |
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling | 1998 |
Role of nitric oxide in cyclosporine A-induced hypertension.
Topics: Animals; Aorta; Arginine; Blood Pressure; Bosentan; Cyclic GMP; Cyclosporine; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hypertension; Immunosuppressive Agents; Male; Nitrates; Nitrites; Olive Oil; Penicillamine; Peptides, Cyclic; Plant Oils; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstriction | 1998 |
Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Pressure; Bosentan; Callithrix; Cyclosporine; Enzyme Inhibitors; Female; Hypertension; Immunosuppressive Agents; Male; Nitrates; Nitric Oxide; Nitrites; Nitroarginine; Rats; Rats, Wistar; Sulfonamides; Systole | 1998 |
R73A and H144Q mutants of the yeast mitochondrial cyclophilin Cpr3 exhibit a low prolyl isomerase activity in both peptide and protein-folding assays.
Topics: Arginine; Binding Sites; Carrier Proteins; Chromatography; Chymotrypsin; Circular Dichroism; Cyclosporine; Escherichia coli Proteins; Histidine; Humans; Kinetics; Mitochondria; Mutation; Peptidylprolyl Isomerase; Protein Binding; Protein Folding; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Substrate Specificity; Tacrolimus | 1999 |
The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion.
Topics: Adjuvants, Immunologic; Animals; Arginine; Blood Transfusion; Cyclosporine; Fatty Acids, Omega-3; Food, Formulated; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; RNA; Tissue Donors; Transplantation, Homologous | 1999 |
Nitric oxide in cyclosporine A-induced hypertension: endothelin receptors gene expression.
Topics: Animals; Aorta; Arginine; Cyclosporine; Gene Expression; Hypertension; Male; Nitrates; Nitric Oxide; Nitrites; Olive Oil; Plant Oils; Rats; Rats, Inbred SHR; Receptors, Endothelin; RNA, Messenger | 1999 |
Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Cyclic GMP; Cyclosporine; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1999 |
Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Arginine; Cyclic GMP; Cyclosporine; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Hypertension; Immunosuppressive Agents; Male; Nitric Oxide; Protein Kinase C; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1999 |
Acute effects of rapamycin on glomerular dynamics: a micropuncture study in the rat.
Topics: Animals; Arginine; Cyclosporine; Glomerular Filtration Rate; Hemodynamics; Immunosuppressive Agents; Insulin; Male; Nitric Oxide; Punctures; Rats; Sirolimus | 2000 |
Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506.
Topics: Animals; Arginine; Cyclosporine; Diet; Dietary Supplements; Fish Oils; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Male; Rats; Rats, Inbred ACI; Rats, Inbred Lew; RNA; Sirolimus; Tacrolimus; Transplantation, Homologous | 2000 |
Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Arterioles; Biglycan; Blood Pressure; Blotting, Northern; Chronic Disease; Collagen; Cyclosporine; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Gene Expression; Glomerular Filtration Rate; Hyalin; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasminogen Activator Inhibitor 1; Proteoglycans; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation.
Topics: Administration, Topical; Animals; Arginine; Biological Transport; Biotinylation; Cyclosporine; Cyclosporins; Humans; Inflammation; Interleukin-2; Ionomycin; Jurkat Cells; Mice; Mice, Inbred BALB C; Molecular Structure; Prodrugs; Skin; Skin Absorption; Tetradecanoylphorbol Acetate | 2000 |
L-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats.
Topics: Amino Acids; Animals; Arginine; Body Weight; Bone and Bones; Bone Density; Collagen; Cyclosporine; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2000 |
Ameliorated effect of L-arginine supplementation on gingival morphology in cyclosporin-treated rats.
Topics: Analysis of Variance; Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Gingiva; Gingival Overgrowth; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2000 |
Role of soy diet and L-arginine in cyclosporin-A-induced osteopenia in rats.
Topics: Animals; Arginine; Body Weight; Bone Density; Bone Diseases, Metabolic; Calcium; Cyclosporine; Diet; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Injections, Intraperitoneal; Male; Pelvic Bones; Radiography; Rats; Rats, Sprague-Dawley; Soybean Proteins; Spine | 2001 |
Effect of arginine on cyclosporine-induced systemic hypertension after cardiac transplantation in the young.
Topics: Adolescent; Adult; Arginine; Blood Pressure; Case-Control Studies; Chromatography, High Pressure Liquid; Citrulline; Cyclosporine; Echocardiography; Female; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Infusions, Intravenous; Male; Ventricular Function, Left | 2001 |
Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
Topics: Acetylcholine; Animals; Arginine; Blood Pressure; Blood Vessels; Cells, Cultured; Cyclosporine; Heart; Heart Rate; Hypertension; Immunosuppressive Agents; Kidney; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Norepinephrine; Organ Size; Oxidative Stress; Potassium Chloride; Rats; Rats, Inbred SHR; Sodium, Dietary; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter.
Topics: 1-Methyl-4-phenylpyridinium; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cations; Cell Line; Cyclosporine; Daunorubicin; Dose-Response Relationship, Drug; Histidine; Humans; Organic Cation Transport Proteins; Rhodamine 123; Time Factors; Tritium; Tyramine; Verapamil; Vinblastine | 2001 |
The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.
Topics: Adult; Age Factors; Alleles; Analysis of Variance; Arginine; Calcium Channel Blockers; Chi-Square Distribution; Codon; Confidence Intervals; Cyclosporine; DNA; Female; Gene Expression Regulation; Genotype; Gingival Overgrowth; Heterozygote; Homozygote; Humans; Immunosuppressive Agents; Kidney Transplantation; Leucine; Logistic Models; Male; Odds Ratio; Polymorphism, Genetic; Proline; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
[Nitric oxide (NO) in a model of renal ischemia and cyclosporine toxicity].
Topics: Animals; Arginine; Cyclosporine; Immunosuppressive Agents; Ischemia; Kidney; Male; Nitric Oxide; Rats; Rats, Wistar; Vasodilator Agents | 2001 |
Stimulation of tetrahydrobiopterin synthesis by cyclosporin A in mouse brain microvascular endothelial cells.
Topics: Animals; Antioxidants; Arginine; Biopterins; Cerebrovascular Circulation; Cycloheximide; Cyclosporine; Endothelium, Vascular; GTP Cyclohydrolase; Immunosuppressive Agents; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Synthesis Inhibitors | 2002 |
Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system.
Topics: Animals; Anticonvulsants; Arginine; Convulsants; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanidines; Kindling, Neurologic; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pentylenetetrazole; Seizures | 2002 |
Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats.
Topics: Animals; Arginine; Creatinine; Cyclosporine; Enzyme Inhibitors; Glutathione Peroxidase; Guanidines; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Tubules; Male; Nephritis, Interstitial; Nitric Oxide Synthase; Rats; Rats, Inbred Strains; Urea | 2002 |
The effect of cyclosporin A on morphine tolerance and dependence: involvement of L-arginine/nitric oxide pathway.
Topics: Analgesics, Opioid; Animals; Arginine; Cyclosporine; Drug Tolerance; Guanidines; Immunosuppressive Agents; Male; Mice; Morphine; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Reaction Time | 2002 |
Effect of immunosuppressive doses of cyclosporine on pancreatic beta cell function in pigs.
Topics: Alanine Transaminase; Animals; Arginine; Bilirubin; Blood Glucose; C-Reactive Protein; Creatinine; Cyclosporine; Glucagon; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Liver; Liver Function Tests; Serum Albumin; Swine | 2002 |
Nitric oxide production modulates cyclosporin A-induced distal renal tubular acidosis in the rat.
Topics: Acidosis, Renal Tubular; Animals; Arginine; Blood Pressure; Body Weight; Creatine; Cyclosporine; Humans; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Protons; Rats; Rats, Wistar; Renal Circulation | 2003 |
Factors involved in the development of hypertension induced by a low-protein diet in rats with renal injury.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Diet, Protein-Restricted; Dietary Supplements; Hypertension; Kidney; Kidney Diseases; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley; Sucrose | 2004 |
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation.
Topics: Arginine; Cells, Cultured; Chemokine CCL2; Cyclosporine; Enalapril; Gene Expression Regulation; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Niacinamide; Thromboplastin | 2003 |
Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
Topics: Acetylcholine; Animals; Arginine; Biological Factors; Cyclooxygenase Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Endothelium-Dependent Relaxing Factors; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Parasympathetic Nervous System; Phenylephrine; Potassium Channel Blockers; Prostaglandins; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Renal Circulation; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2004 |
Simvastatin and L-arginine preserve renal function after ischemia/reperfusion injury.
Topics: Animals; Arginine; Cyclosporine; Drug Therapy, Combination; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Simvastatin | 2005 |
Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Topics: Administration, Oral; Animals; Arginine; Cyclosporine; Dose-Response Relationship, Drug; Drinking; Drug Therapy, Combination; Enzyme Inhibitors; Immunosuppressive Agents; Injections, Subcutaneous; Kidney Diseases; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Rats; Water Supply | 2005 |
Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands.
Topics: Animals; Arginine; Calcium; Cell Line, Tumor; Cyclosporine; HeLa Cells; Humans; Hydrogen Bonding; Intracellular Membranes; Ion Channels; Membrane Potentials; Mitochondria; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Models, Chemical; Permeability; Phenylglyoxal; Protein Binding; Protein Conformation; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2005 |
Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.
Topics: Animals; Arginine; Atrophy; Cyclosporine; Dietary Supplements; Female; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley | 2005 |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Living Donors; Male; Prospective Studies; Tacrolimus; Treatment Outcome | 2005 |
Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Arginine; Calcineurin Inhibitors; Cyclosporine; Fatty Acids, Monounsaturated; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Rapeseed Oil; Sirolimus; T-Lymphocytes | 2006 |
Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.
Topics: Amidines; Animals; Arginine; Blood Pressure; Bradykinin; Cyclosporine; Cytochrome P-450 Enzyme System; Endothelin-1; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Nitric Oxide; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Triazoles | 2006 |
Oral L-arginine protects against cyclosporine-induced hepatotoxicity in rats.
Topics: Administration, Oral; Animals; Arginine; Cyclosporine; Enzyme Inhibitors; Female; Immunosuppressive Agents; Liver; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2008 |
A nonessential role for Arg 55 in cyclophilin18 for catalysis of proline isomerization during protein folding.
Topics: Arginine; Carbonic Anhydrase II; Catalytic Domain; Cyclophilin A; Cyclosporine; Escherichia coli; Humans; Isomerism; Kinetics; Mutation; Peptides; Protein Engineering; Protein Folding | 2009 |
Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Arginine; Behavior, Animal; Brain; Cognition Disorders; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Male; Maze Learning; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Tacrolimus; Time Factors | 2009 |
L-arginine supplementation improves exercise capacity after a heart transplant.
Topics: Arginine; Blood Pressure; Cyclosporine; Dietary Supplements; Double-Blind Method; Echocardiography; Endothelin-1; Endothelins; Exercise Test; Exercise Tolerance; Heart Rate; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Nitric Oxide; Patient Selection; Placebos; Pulmonary Artery; Quality of Life | 2010 |
Role of PPAR gamma/nitric oxide synthase signaling in the cyclosporine-induced attenuation of endothelium-dependent renovascular vasodilation.
Topics: Anilides; Animals; Arginine; Carbachol; Cyclosporine; Endothelium-Dependent Relaxing Factors; Immunosuppressive Agents; In Vitro Techniques; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylephrine; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Signal Transduction; Thiazolidinediones; Vasoconstrictor Agents; Vasodilation | 2010 |
Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats.
Topics: Animals; Arginine; Chemical and Drug Induced Liver Injury; Cyclosporine; Immunosuppressive Agents; Kidney Diseases; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Trapidil; Vasodilator Agents | 2010 |
Effects of cryogenic sample analysis on molecular depth profiles with TOF-secondary ion mass spectrometry.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Arginine; Cyclosporine; Deuterium Oxide; Oligopeptides; Spectrometry, Mass, Secondary Ion; Temperature | 2010 |
TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Topics: Adenine; Adolescent; Adult; Aged; Arginine; Case-Control Studies; Codon; Cyclosporine; Cytosine; Female; Gene Frequency; Genotype; Gingival Overgrowth; Guanine; Haplotypes; Humans; Immunosuppressive Agents; Kidney Transplantation; Leucine; Male; Middle Aged; Polymorphism, Single Nucleotide; Proline; Promoter Regions, Genetic; Thymine; Transforming Growth Factor beta1; Young Adult | 2011 |
The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients.
Topics: Adult; Arginine; Calcineurin Inhibitors; Cyclosporine; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Nitric Oxide Synthase; P-Selectin; Platelet Activation; Platelet Aggregation; Tacrolimus | 2011 |
Late effects of renal transplantation on endothelial functions and cardiac morphology.
Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Cyclosporine; Endothelium, Vascular; Female; Heart; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Tunica Intima | 2011 |
Cyclosporine attenuates arginine transport, in human endothelial cells, through modulation of cationic amino acid transporter-1.
Topics: Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Cyclosporine; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunosuppressive Agents; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Protein Kinase C-alpha | 2013 |
Severe decrease of cyclosporine levels in a heart transplant recipient receiving the direct thrombin inhibitor argatroban.
Topics: Antithrombins; Arginine; Creatinine; Cyclosporine; Cytochrome P-450 CYP3A Inducers; Drug Antagonism; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Pipecolic Acids; Sulfonamides; Transplant Recipients | 2014 |
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden | 2014 |
Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy.
Topics: Adiponectin; Adult; Arginine; Biomarkers; Blood Platelets; Case-Control Studies; Cyclosporine; Drug Therapy, Combination; Endothelial Cells; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Function Tests; Risk Factors; Tacrolimus; Treatment Outcome; Up-Regulation; Young Adult | 2015 |
The studies of N-Octyl-N-Arginine-Chitosan coated liposome as an oral delivery system of Cyclosporine A.
Topics: Administration, Oral; Animals; Arginine; Chitosan; Cyclosporine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Emulsions; Gastrointestinal Tract; Immunosuppressive Agents; Liposomes; Male; Particle Size; Rats; Rats, Sprague-Dawley | 2015 |
Nebivolol suppresses asymmetric dimethylarginine and attenuates cyclosporine-induced nephrotoxicity and endothelial dysfunction in rats.
Topics: Acute Kidney Injury; Adrenergic beta-1 Receptor Agonists; Animals; Arginine; Cyclosporine; Dose-Response Relationship, Drug; Endothelium, Vascular; Immunosuppressive Agents; Male; Nebivolol; Nitric Oxide Synthase Type II; Organ Culture Techniques; Oxidative Stress; Rats; Rats, Wistar | 2016 |
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Aminoquinolines; Aphidicolin; Apoptosis; Benzamides; Calcium; Calmodulin; Camptothecin; Cell Cycle; Chromatin; Cyclosporine; DNA; Egtazic Acid; Ethers, Cyclic; Humans; Isoquinolines; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Naphthalenes; Okadaic Acid; Phosphoprotein Phosphatases; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Polycyclic Compounds; Protein Kinase C; Spermine; Staurosporine; Teniposide; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Zinc | 1993 |
O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
Topics: Biotransformation; Catalysis; Catechols; Chromatography, High Pressure Liquid; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Erythromycin; Etoposide; Humans; Methylation; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Teniposide | 1994 |
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
Topics: Cyclosporine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Flunarizine; Humans; Leukemia, T-Cell; Piperidines; Quinidine; Teniposide; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Cyclosporine; Eye Neoplasms; Fundus Oculi; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Laser Therapy; Pilot Projects; Retinoblastoma; Teniposide; Vincristine; Visual Acuity | 1996 |
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine | 2004 |